We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Momenta Hits Teva With Suit to Delay Lovenox Competition
Momenta Hits Teva With Suit to Delay Lovenox Competition
December 7, 2010
With Teva Pharmaceutical Industries believed to be on the verge of gaining FDA approval for its generic version of Lovenox, Momenta Pharmaceuticals — the only company with a generic version of Sanofi-Aventis’ blood-thinner currently on the market — has filed suit against Teva claiming patent infringement.